← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Candel Therapeutics CADL $682M	20	+8	+67%	$54.4M
102	KRBP 102 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	20	-3	-13%	$3.82M
103	103 Estrella Immunopharma ESLA $23.3M	19	+3	+19%	$32.4M
104	FRLN 104 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	18	-2	-10%	$26M
105	105 Benitec Biopharma BNTC $295M	17	-1	-6%	$4.16M
106	LGVN 106 Longeveron LGVN $4.78M	17	+5	+42%	$5.55M
107	107 IN8bio INAB $11.7M	13	0	0%	$7.8M
108	108 Immix Biopharma IMMX $720M	11	+11	–	$5.47M
109	109 BioRestorative Therapies BRTX $2.02M	10	+10	–	$1.72M
110	CYAD 110 DELISTED Celyad Oncology SA American Depositary Shares CYAD	10	+3	+43%	$24.2M
111	111 Creative Medical Technology CELZ $6.21M	8	+8	–	$441K
112	112 NewcelX Ltd NCEL $16.5M	7	+2	+40%	$145K
113	113 Genenta Science GNTA $32.3M	2	+2	–	$517K
114	114 DELISTED Arcellx ACLX	–	–	–	–
115	115 Artiva Biotherapeutics ARTV $296M	–	–	–	–
116	116 Coya Therapeutics COYA $102M	–	–	–	–
117	117 DELISTED CARGO Therapeutics CRGX	–	–	–	–
118	118 enGene Therapeutics ENGN $115M	–	–	–	–
119	119 FibroBiologics FBLG $7.08M	–	–	–	–
120	120 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
121	GRML 121 Greenland Mines Ltd GRML $92.9M	–	–	–	–
122	122 Fractyl Health GUTS $55.2M	–	–	–	–
123	123 Kyverna Therapeutics KYTX $369M	–	–	–	–
124	124 Lexeo Therapeutics LXEO $227M	–	–	–	–
125	125 Metagenomi Therapeutics MGX $31.9M	–	–	–	–